Sharing-our-perspective-page-header2



Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward


  • FDA approves first non-opioid medication for opioid withdrawal symptoms

    by
    | May 17, 2018
    Tag Icon
    Workers' Compensation, Opioids
    the FDA approved Lucemyra™ (lofexidine hydrochloride) for the mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults.


  • Oklahoma enacts opioid prescribing restrictions

    by
    • Optum Workers' Comp
    | May 08, 2018
    Tag Icon
    Pain Management, Opioids, Formularies
    Oklahoma Senate Bill 1446, effective November 1, 2018, limits opioid pain medication to a 7 day-supply.


  • North Carolina Workers’ Comp. Opioid Treatment Rules Approved

    by
    • Optum Workers' Comp
    | May 01, 2018
    Tag Icon
    Pain Management, Opioids, Formularies
    North Carolina’s Rules Review Commission (RRC) recently approved the opioid treatment rules submitted by the North Carolina Industrial Commission. The new rules address requirements for the use of opioid analgesics, related prescriptions and pain management treatment for injured workers in both the acute and chronic phases.


  • Pennsylvania Legislature passes workers’ compensation drug formulary bill

    by
    • Optum Workers' Comp
    | Apr 20, 2018
    Tag Icon
    Formularies
    On April 16, 2018, the Pennsylvania General Assembly took a step forward in requiring utilization of a drug formulary for workers’ compensation claims in the state. Senate Bill 936, originally failed to pass the House in February on a tie vote of 98-98, however the House approved it this week by a slim margin of 101-92. The bill now heads to Governor Tom Wolf’s desk for his action.




Do you have a question for our
Government Affairs team?






Subscribe

Stay informed by signing up to receive our latest update. *Denotes a required field